Health authorities in Vadodara have started an investigation after two children fell unconscious following consumption of a cough syrup dose exceeding recommended levels.
Glimpse:
In Dabhoi (Vadodara district), two children aged about 2.5 and 5 years were admitted to hospital in critical condition after receiving an adult dose of a cough syrup. Samples have been collected for lab testing while officials examine prescribing practices and supply channels.
A serious health incident has triggered a regulatory probe in Gujarat: health and drug officials in Vadodara district are investigating after two young children fell ill after taking a cough syrup. Reports suggest the dosage administered was meant for adults, which may have escalated the adverse reaction.
The syrup identified as Sudex DS, manufactured by Leo Formulations is not approved for use in children under seven. District authorities have already collected samples from the patient’s home and pharmacy for lab analysis. The prescribing doctor is under evaluation, and authorities are looking into licensing, supply chain, and whether labelling or prescription violations occurred.
“Child safety demands zero margin for error any deviation must be thoroughly scrutinized.”
By
HB Team
